Veracyte, Inc. (VCYT) stock
VCYTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3029% below fair value
$25.13+0.09 (+0.36%)
Close on Nov 20, 2026Market cap $2.02BP/E 17.9Yield –
Veracyte net income
Net income is the profit left for shareholders after every expense, interest and tax.
Veracyte's net income for the twelve months ending Jun 30, 2026 was $114.48M, up 334.7% year over year. For fiscal 2025 it was $66.35M, up 174.9% from the year before. The highest annual figure on record is $66.35M in fiscal 2025.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $66.35M | +174.9% |
| FY2024 | Dec 31, 2024 | $24.14M | – |
| FY2023 | Dec 31, 2023 | -$74.40M | – |
| FY2022 | Dec 31, 2022 | -$36.56M | – |
| FY2021 | Dec 31, 2021 | -$75.56M | – |
| FY2020 | Dec 31, 2020 | -$34.91M | – |
| FY2019 | Dec 31, 2019 | -$12.60M | – |
| FY2018 | Dec 31, 2018 | -$23.00M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $25.49M | – |
| Q1 FY2026 | Mar 31, 2026 | $28.71M | +307.4% |
| Q4 FY2025 | Dec 31, 2025 | $41.15M | +704.8% |
| Q3 FY2025 | Sep 30, 2025 | $19.14M | +26.3% |
| Q2 FY2025 | Jun 30, 2025 | -$980.00K | -117.1% |
| Q1 FY2025 | Mar 31, 2025 | $7.05M | – |
| Q4 FY2024 | Dec 31, 2024 | $5.11M | – |
| Q3 FY2024 | Sep 30, 2024 | $15.16M | – |
| Q2 FY2024 | Jun 30, 2024 | $5.73M | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.86M | – |
| Q4 FY2023 | Dec 31, 2023 | -$28.29M | – |
| Q3 FY2023 | Sep 30, 2023 | -$29.62M | – |
| Q2 FY2023 | Jun 30, 2023 | -$8.40M | – |
| Q1 FY2023 | Mar 31, 2023 | -$8.09M | – |
| Q4 FY2022 | Dec 31, 2022 | -$3.84M | – |
| Q3 FY2022 | Sep 30, 2022 | -$8.72M | – |
| Q2 FY2022 | Jun 30, 2022 | -$9.53M | – |
| Q1 FY2022 | Mar 31, 2022 | -$14.46M | – |
| Q4 FY2021 | Dec 31, 2021 | -$10.53M | – |
| Q3 FY2021 | Sep 30, 2021 | -$14.13M | – |
| Q2 FY2021 | Jun 30, 2021 | -$9.04M | – |
| Q1 FY2021 | Mar 31, 2021 | -$41.87M | – |
| Q4 FY2020 | Dec 31, 2020 | -$8.04M | – |
| Q3 FY2020 | Sep 30, 2020 | -$4.12M | – |
| Q2 FY2020 | Jun 30, 2020 | -$11.03M | – |
| Q1 FY2020 | Mar 31, 2020 | -$11.72M | – |
| Q4 FY2019 | Dec 31, 2019 | -$7.46M | – |
| Q3 FY2019 | Sep 30, 2019 | -$730.00K | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.49M | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.92M | – |
See a number that looks wrong?